• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对巴雷特食管293例内镜切除标本进行组织学评估。

Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus.

作者信息

Peters Femke P, Brakenhoff Klasina P M, Curvers Wouter L, Rosmolen Wilda D, Fockens Paul, ten Kate Fiebo J W, Krishnadath Kausilia K, Bergman Jacques J G H M

机构信息

Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Gastrointest Endosc. 2008 Apr;67(4):604-9. doi: 10.1016/j.gie.2007.08.039. Epub 2007 Dec 26.

DOI:10.1016/j.gie.2007.08.039
PMID:18155214
Abstract

BACKGROUND

Evidence-based selection criteria for endoscopic resection (ER) of Barrett's neoplasia are scarce.

OBJECTIVE

To study the histopathology of ER specimens of Barrett's neoplasia and correlate this with endoscopic characteristics to make recommendations for patient management. DESIGN, SETTING, INTERVENTIONS: Histology and correlating endoscopy reports of specimens obtained at 293 consecutive ERs performed at a Dutch tertiary referral center between 2000 and 2006 were reviewed.

MAIN OUTCOME MEASUREMENTS

Histologic findings in ER specimens and their relation with endoscopic characteristics.

RESULTS

A total of 150 ERs were performed for focal lesions: 16% type 0-I, 23% 0-IIa, 7% 0-IIb, 3% 0-IIc, 9% 0-IIa-IIb, and 42% 0-IIa-IIc; and 143 for flat mucosa. Histology revealed no dysplasia in 57 ERs, low-grade intraepithelial neoplasia in 52, high-grade intraepithelial neoplasia in 104, T1m in 61, and T1sm in 17; in two cancers, infiltration depth was not assessable because of artifacts. Type 0-I and 0-IIc lesions significantly more often penetrated the submucosa (P = .009): 60% were G1 cancers, 23% were G2 cancers, and 18% were G3 cancers. G2-G3 cancers significantly more often invaded the submucosa (P < .001) or had positive vertical margins (P = .015). Histology of ER specimens led to a change in diagnosis in 49% of the focal lesions and a relevant change in treatment policy in 30%.

LIMITATIONS

A retrospective study.

CONCLUSIONS

ER is a valuable diagnostic tool that frequently leads to a change in treatment policy. Most endoscopically resected early Barrett's neoplasia are 0-II type, G1 mucosal neoplasia. Submucosal infiltration is more often encountered in type 0-I and 0-IIc lesions and in G2-G3 cancers.

摘要

背景

巴雷特肿瘤内镜切除术(ER)的循证选择标准稀缺。

目的

研究巴雷特肿瘤ER标本的组织病理学,并将其与内镜特征相关联,为患者管理提供建议。

设计、设置、干预措施:回顾了2000年至2006年在一家荷兰三级转诊中心连续进行的293例ER所获取标本的组织学及相关内镜报告。

主要观察指标

ER标本的组织学发现及其与内镜特征的关系。

结果

共对局灶性病变进行了150例ER:0-I型占16%,0-IIa型占23%,0-IIb型占7%,0-IIc型占3%,0-IIa-IIb型占9%,0-IIa-IIc型占42%;对扁平黏膜进行了143例ER。组织学检查显示,57例ER标本无发育异常,52例为低级别上皮内瘤变,104例为高级别上皮内瘤变,61例为T1m,17例为T1sm;在2例癌症中,由于人为因素无法评估浸润深度。0-I型和0-IIc型病变穿透黏膜下层的情况明显更常见(P = 0.009):60%为G1癌,23%为G2癌,18%为G3癌。G2-G3癌侵犯黏膜下层(P < 0.001)或垂直切缘阳性(P = 0.015)的情况明显更常见。ER标本的组织学检查导致49%的局灶性病变诊断改变,30%的治疗策略发生相关改变。

局限性

一项回顾性研究。

结论

ER是一种有价值的诊断工具,经常导致治疗策略的改变。大多数经内镜切除的早期巴雷特肿瘤为0-II型,G1黏膜肿瘤。0-I型和0-IIc型病变以及G2-G3癌更常出现黏膜下层浸润。

相似文献

1
Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus.对巴雷特食管293例内镜切除标本进行组织学评估。
Gastrointest Endosc. 2008 Apr;67(4):604-9. doi: 10.1016/j.gie.2007.08.039. Epub 2007 Dec 26.
2
Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions.对380个病变中早期巴雷特肿瘤的宏观类型和位置进行前瞻性评估。
Endoscopy. 2007 Jul;39(7):588-93. doi: 10.1055/s-2007-966363.
3
Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.巴雷特食管合并高级别异型增生或黏膜内癌患者初次内镜黏膜切除术标本中鳞状上皮下的高级病理学表现:对监测和内镜治疗管理的意义
Gastrointest Endosc. 2009 Sep;70(3):417-21. doi: 10.1016/j.gie.2009.01.047. Epub 2009 Jun 24.
4
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.完全性巴雷特食管根除性内镜黏膜切除术:治疗高级别异型增生和黏膜内癌的有效治疗方式——一项美国单中心经验
Am J Gastroenterol. 2009 Nov;104(11):2684-92. doi: 10.1038/ajg.2009.465. Epub 2009 Aug 18.
5
Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia.对326例巴雷特食管和早期肿瘤患者的内镜切除标本进行组织学分析。
Endoscopy. 2004 Sep;36(9):776-81. doi: 10.1055/s-2004-825802.
6
Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.早期肿瘤性巴雷特食管的治疗:内镜治疗与食管切除术的比较
Gastrointest Endosc. 2008 Apr;67(4):595-601. doi: 10.1016/j.gie.2007.08.042. Epub 2008 Feb 14.
7
Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus.巴雷特食管高级别上皮内瘤变的根治性治疗。
Endoscopy. 2005 Oct;37(10):999-1005. doi: 10.1055/s-2005-870352.
8
Diagnosis of early neoplasia in Barrett's mucosa based on changes in surface structure. Comparative stereo-microscopic and histological investigations in 600 endoscopically resected specimens.基于表面结构变化诊断Barrett黏膜早期肿瘤形成。对600例经内镜切除标本进行比较立体显微镜检查和组织学研究。
Z Gastroenterol. 2010 May;48(5):542-5. doi: 10.1055/s-0028-1109937. Epub 2010 May 6.
9
Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort.早期肿瘤性巴雷特食管的逐步根治性内镜切除术:布鲁塞尔队列报告
Endoscopy. 2008 Nov;40(11):892-8. doi: 10.1055/s-2008-1077675. Epub 2008 Nov 13.
10
Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.内镜黏膜切除术实现完全巴雷特食管消除(CBE-EMR)治疗高级别异型增生和黏膜内癌的长期随访
Endoscopy. 2007 Dec;39(12):1086-91. doi: 10.1055/s-2007-966788. Epub 2007 Aug 15.

引用本文的文献

1
Management of Barrett's Esophagus: Practice-Oriented Answers to Clinical Questions.巴雷特食管的管理:临床问题的实用解答
Cancers (Basel). 2023 Mar 23;15(7):1928. doi: 10.3390/cancers15071928.
2
Surveillance in Barrett's Esophagus: Challenges, Progress, and Possibilities.巴雷特食管的监测:挑战、进展与可能。
Gastroenterology. 2023 Apr;164(5):707-718. doi: 10.1053/j.gastro.2023.01.031. Epub 2023 Feb 4.
3
Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.发育不良性 Barrett 食管和早期食管腺癌的处理。
Gastroenterol Clin North Am. 2022 Sep;51(3):485-500. doi: 10.1016/j.gtc.2022.06.004. Epub 2022 Aug 30.
4
Endoscopic Management of Esophageal Cancer.食管癌的内镜治疗
Cancers (Basel). 2022 Jul 22;14(15):3583. doi: 10.3390/cancers14153583.
5
Clinicopathologic correlations of superficial esophageal adenocarcinoma in endoscopic submucosal dissection specimens.内镜黏膜下剥离术标本中表浅型食管腺癌的临床病理相关性。
Diagn Pathol. 2021 Nov 27;16(1):111. doi: 10.1186/s13000-021-01169-1.
6
Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy.Barrett 食管的进化动态:对监测、风险分层和治疗的影响。
Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):95-111. doi: 10.1038/s41575-021-00531-4. Epub 2021 Nov 2.
7
Best Practices in Surveillance for Barrett's Esophagus.巴雷特食管监测的最佳实践
Gastrointest Endosc Clin N Am. 2021 Jan;31(1):59-75. doi: 10.1016/j.giec.2020.08.003. Epub 2020 Oct 21.
8
A narrative review of Barrett's esophagus in 2020, molecular and clinical update.2020年巴雷特食管的叙述性综述:分子与临床进展
Ann Transl Med. 2020 Sep;8(17):1107. doi: 10.21037/atm-20-4406.
9
Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus.巴雷特食管早期癌症和高级别异型增生的手术与根治性内镜治疗对比
Cochrane Database Syst Rev. 2020 May 22;5(5):CD007334. doi: 10.1002/14651858.CD007334.pub5.
10
Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus.坚持预设的基准质量标准,有资格成为 Barrett 食管活检中不典型增生的专家评估者 - 迈向 Barrett 食管的数字审查。
United European Gastroenterol J. 2019 Aug;7(7):889-896. doi: 10.1177/2050640619853441. Epub 2019 May 21.